Thomas Michniacki, MD
Manage Your Profile
About
Dr. Thomas Michniacki was raised in Memphis, Michigan and attended the University of Michigan for his undergraduate studies. Following graduation from the University of Michigan Medical School, he completed his pediatric residency training at the University of Colorado/Children’s Hospital Colorado. Dr. Michniacki returned to his home state of Michigan for his fellowship training in pediatric hematology/oncology at the University of Michigan and is now a faculty member within the department. His clinical and research interests include immune-mediated hematologic disorders, bone marrow failure syndromes/aplastic anemia and primary immunodeficiencies. He enjoys attending University of Michigan sporting events and exploring the city of Ann Arbor with his family.
Links
https://www.mottchildren.org/profile/32879/thomas-frank-michniacki-md
Qualifications
-
Pediatric Hematology/Oncology FellowshipUniversity of Michigan/C.S. Mott Children's Hospital, United States
2016 - 2019
Postdoctoral Fellowship
-
Postdoctoral Research Fellow (Dr. JoAnn Sekiguchi Laboratory)Human Genetics/Internal Medicine Department, University of Michigan, United States
2017 - 2019
Postdoctoral Research
-
ResidencyChildren's Hospital Colorado/University of Colorado/Denver Health Medical Center, Pediatrics, United States
2013 - 2016
Residency
-
Diagnostic School in Primary Immunodeficiency Diseases (2018)Clinical Immunology Society/American Academy of Asthma, Allergy & Immunology, United States
Other
-
Clinical Immunology Society School in Primary Immunodeficiency Diseases (2019)Clinical Immunology Society, United States
Other
-
MDUniversity of Michigan Medical School, Ann Arbor, MI, United States
2009 - 2013
-
BSUniversity of Michigan, Ann Arbor, Michigan, United States
2004 - 2008
Research Overview
Pediatric Hematology/Oncology, Immuno-Hematology, Primary Immunodeficiencies, Immunology, Bone Marrow Failure Syndromes/Aplastic Anemia, and Lymphoproliferative Diseases
Quality of life and patient reported outcomes in those with bone marrow failure and inborn errors of immunity conditions
Recent Publications
-
Gloude NJ, Brundige K, Loveless S, Atkinson I, Chandra S, Cooper R, Coyne K, Dusa C, Galvin A, Geddis A, Joos M, Malsch M, Michniacki T, Millecker J, Walkovich K, Shimamura A, Myers KC. Br J Haematol, 2026 May 25;Journal ArticleBeyond neutropenia: Immunological evaluation of patients with Shwachman-Diamond syndrome.
DOI:10.1111/bjh.70553 PMID: 42185746 -
Renberg A, Coppersmith S, Merritt O, Heider A, Helms A, Michniacki T, Luxford J, Josephi-Taylor S, Roberts P, Meisner J. Am J Med Genet A, 2026 Apr 3;Journal ArticleTargeted Anti-IL-1 Immunomodulatory Therapy in Pediatric Onset PPP1R13L-Related Arrhythmogenic Cardiomyopathy.
DOI:10.1002/ajmg.a.70156 PMID: 41928611 -
Jasthi D, Donahue M, Michniacki T, Freigeh G. Annals of Allergy Asthma & Immunology, 2025 Nov 7; 135 (5): s184Proceeding / Abstract / PosterSTAT1 GOF MASQUERADING AS INFLAMMATORY BOWEL DISEASE
DOI:10.1016/j.anai.2025.08.560 -
McCormick AD, Fifer C, Owens S, Hansen J, Lu J, Whiteside W, Zitterman V, Craven A, Schumacher K, Schwartz I, Quain A, Joynt M, Connell P, Shakhin V, Lindner C, Modi Z, Saba T, McGrath M, Michniacki T, Hendrix G, Cousino M, Goldberg C, Uzark K. 2025Additional ScholarshipClinical practice guideline: Longitudinal follow up after Fontan palliation for pediatric patients
-
Bayes MG, Michniacki TF, Keren DF, Farran SH, Murray DL, Manthei DM. Clinical Chemistry, 2024 Oct 3; 70 (Supplement_1): hvae106.451Proceeding / Abstract / PosterB-089 Pseudo-clonal Increased IgG4 with Polyclonal Distribution Demonstrated by MALDI-TOF-MS in a Pediatric Patient with Tricho-Hepato-Enteric Syndrome (THES)
DOI:10.1093/clinchem/hvae106.451 -
Bou-Maroun L, Walkovich K, Weinberg J, Leopold K, Hanibal M, Frazier L, Michniacki T. Clinical Immunology, 2024 Apr 25; 262: 110073Proceeding / Abstract / Poster131 A Peculiar Presentation: STAT3 Loss of Function with Recurrent Osteomyelitis and Review of the Literature
DOI:10.1016/j.clim.2024.110073 -
Pruitt J, Walkovich K, Lake N, Hanibal M, Frazier L, Michniacki T. Clinical Immunology, 2024 Apr 25; 262: 110108Proceeding / Abstract / Poster166 PRF1-Related Isolated CNS Hemophagocytic Lymphohistiocytosis Successfully Treated with Ruxolitinib Monotherapy
DOI:10.1016/j.clim.2024.110108 -
Michniacki TF, Walkovich KJ. 2024 Jan 1; Nelson Textbook of Pediatrics Volume 1 2, 1304 - 1312.e1.ChapterLeukopenia
DOI:10.1016/B978-0-323-88305-4.00171-1